Healthcare isn't the hottest sector these days. While the S&P 500 has soared nearly 21% over the last 12 months, healthcare ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
SpotDraft’s software includes AI-assisted redlining tools, which is the process of editing a contract where two or more ...
Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...
Google also released an experimental version of Gemini 2.0 Pro, the company’s flagship model with the best performance for ...
On Thursday, Jan. 30, The U.S. Food and Drug Administration announced that it has approved a new non-opioid painkiller pill ...
Hosted on MSN22d
MaxCyte: Building the Future of Cell and Gene Therapy InnovationMaxcyte's technology helped Vertex Pharmaceuticals Inc. (NASDAQ ... usually at a 45-degree or higher angle. The flagpole completes when the stock forms its peak. The flag is formed on the parallel ...
HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...
Along with its gene editing therapy Casgevy, Vertex is offering fertility preservation support for its patients—a program that the HHS claims violates anti-kickback statutes. In a court filing on ...
The kickstand has a new design and can support the Switch 2 from a much lower angle, all the way down to horizontal. Handy! Image credit: Nintendo Onto the Switch 2 Joy-Con, which have been given ...
Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results